Back to UBS Group AG UBS Group AG

KPTIKPTI
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in KARYOPHARM THERAPEUTICS INC

UBS Group AG holds 353,545 shares of KPTI (KARYOPHARM THERAPEUTICS INC), worth $3.5M as of 2026-Q2. The position was increased (+82.2% shares). KPTI represents 0.0% of UBS Group AG's portfolio.

Current Value

$3.5M

Current Shares

353,545

Total Value Change

+$3.1M

Total Shares Change

+259,933

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
353,545
+82.2%
$3.5M0.0%$9.77
41
2026-Q1
Increased
194,017
+119.3%
$1.1M0.0%$9.13
41
2025-Q4
Increased
88,455
+48.2%
$651,0290.0%$7.31
34
2025-Q3
Decreased
59,685
-63.1%
$390,3400.0%$6.35
0
2025-Q2
Increased
161,900
+73.0%
$697,7890.0%$4.39
37
2025-Q1
New
93,612
-
$350,1090.0%$4.16
33

Other major holders of KPTI: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., GOLDMAN SACHS GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used